Open Journal of Blood Diseases

Vol.1 No.2(2011), Paper ID 8941, 3 pages

DOI:10.4236/ojbd.2011.12004

 

Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate

 

Christophe Martinaud, Aurélie Mayet, Sophie Bousquet, Nathalie Beaufils, Jean Gabert, Sophie Raynaud, Marie-Joelle Mozziconacci

 

 

Copyright © 2011 Christophe Martinaud, Aurélie Mayet, Sophie Bousquet, Nathalie Beaufils, Jean Gabert, Sophie Raynaud, Marie-Joelle Mozziconacci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Martinaud, C. , Mayet, A. , Bousquet, S. , Beaufils, N. , Gabert, J. , Raynaud, S. and Mozziconacci, M. (2011) Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate. Open Journal of Blood Diseases, 1, 12-14. doi: 10.4236/ojbd.2011.12004.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.